Altimmune
Morristown, New Jersey, United States · Biopharma, Biotechnology, Health Care
Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD) and obe
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Morristown, New Jersey, United States
- Employees
- 59
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Public (ALT)
- Website
- altimmune.com
- Company page
Recent activity at Altimmune
- : SEC 8-K (5.02):
- : Altimmune Appoints Richard Menziuso as Vice President, Global Controller
- : SEC 8-K (5.02): On September 24, 2026, Altimmune, Inc. appointed Richard Menziuso as the Vice President, Global Controller and Principal Accounting Officer, effective September 29, 2026. Mr. Menziuso brings 28 years of finance and accounting experience, notably serving as Vice President, Corporate Controller at Centessa Pharmaceuticals until its recent acquisition by Eli Lilly. His appointment is expected to enhance the financial leadership of Altimmune as they continue to advance in the biopharmaceutical sector. Gregory Weaver will maintain his position as the Chief Financial Officer, ensuring continuity in the company's financial strategy during this transition.
About Altimmune: questions and answers
What does Altimmune do?
Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD) and obe
Where is Altimmune headquartered?
Altimmune is headquartered in Morristown, New Jersey, United States.
How many employees does Altimmune have?
Altimmune has about 59 employees.
What is the latest news on Altimmune?
On Oct 27, 2026, SEC 8-K (5.02):
Is Altimmune a public company?
Yes. Altimmune is publicly traded under the ticker ALT.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy